Medication-related osteonecrosis of the jaw (MRONJ) is primarily associated with
administering antiresorptive or antiangiogenic drugs. Despite significant research on …

Objective The aim of this comprehensive systematic review and meta‐analysis was to
investigate the pathology and pathogenesis of medication‐related osteonecrosis of the jaw …

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is defined as an exposed
necrotic bone in the oral cavity that does not heal after appropriate intervention for> 8 weeks …

Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse effect of
antiresorptive and antiangiogenic therapies. MRONJ is identified by chronic wounds in the …

Purpose There is much concern about the increasing number of patients with medication-
related osteonecrosis of the jaw (MRONJ), and many studies have been published in an …

Objective This study aimed to evaluate the dose–response effects of ionizing radiation (IR)
on alveolar bone repair and bone strength after tooth extraction. Materials and methods A …

Due to their inhibitory effects on resorption, bisphosphonates are widely used in the
treatment of diseases associated to an extensive bone loss. Yet, little is known about …

The aim of this systematic review was to answer the following question:“Does alendronate, a
nitrogen-containing bisphosphonate, improve or impair alveolar socket healing after tooth …

Enoxacin inhibits binding between the B-subunit of vacuolar H+-ATPase (V-ATPase) and
microfilaments, and also between osteoclast formation and bone resorption in vitro. We …

Background It has been shown that the oral aminobisphosphonate sodium alendronate
(ALN) therapy reduces the risk of main fractures in osteoporotic women, but its effect on the …